Bryan Haugen MD

Thyroid

Professor of Medicine, University Colorado School of Medicine, Head, Division of Endocrinology, Metabolism and Diabetes

12801 E 17th AveRoom 7100Aurora, CO 80045
Phone+1 303-724-3921
Fax+1 303-724-3920

Dr. Haugen is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haugen's full profile Already have an account?

Education & Training

University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1993
University of ColoradoResidency, Internal Medicine, 1987 - 1990
Mayo Clinic College of MedicineClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CO State Medical License 1989 - 2027

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Is Levothyroxine Alone Adequate Thyroid Hormone Replacement? Start of enrollment: 2016 Nov 01
Terminated
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) Start of enrollment: 2018 Feb 07
COMPLETED
PHASE2

Publications & Presentations

PubMed

Genetic drivers of etiologic heterogeneity in thyroid cancer.
Yon Ho Jee, Nikita Pozdeyev, Christopher R Gignoux, Samantha White, Bryan R Haugen
Nature Communications. 2026-07-10
1 citations
Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific Proteins and Neo-antigens in Follicular Cell-derived Thyroid Cancers.
Breaunna Garza, Jacob Calhoun, Paul J Norman, Noah Cline, Katherine M Kichula
The Journal of Clinical Endocrinology and Metabolism. 2026-04-22
2 citations
Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases.
Samantha L White, Maizy S Brasher, Jack Pattee, Wei Zhou, Sinéad Chapman
Nature Genetics. 2026-02-01

Lectures

Thyroid Cancer: When Is Lobectomy Not Enough?
ENDO 2019 - New Orleans, LA - 3/25/2019
New Medical Options for the Treatment of Advanced Thyroid Cancer
ENDO 2019 - New Orleans, LA - 3/24/2019
Thyroid Cancer: When Is Lobectomy Not Enough? (Repeat)
ENDO 2019 - New Orleans, LA - 3/25/2019

Press Mentions

GLP-1s Don’t Raise DTC Recurrence Risk, Study SaysSeptember 12th, 2025
CU Department of Medicine Senior Faculty Help Support Promising Junior ResearchersMay 20th, 2025
CU Cancer Center Research Tests Two-Drug Treatment for Progressive Thyroid CancerSeptember 23rd, 2024